Condition
Drug Susceptible Pulmonary Tuberculosis
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07525427Phase 2RecruitingPrimary
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
NCT07608172Not ApplicableNot Yet Recruiting
Short-Course Regimens for DS-PTB in AIDS Patients
NCT07517445Phase 2RecruitingPrimary
Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis
Showing all 3 trials